Long-term Outcomes from Re-resection for High-risk Non–muscle-invasive Bladder Cancer: A Potential to Rationalize Use

European Urology Focus

Volumn 5, Issue 4, 2019, Pages 650-657

  Gordon, Patrick C ^a   Thomas, Francis ^b   Noon, Aidan P ^a   Rosario, Derek J ^a   Catto, James W F ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b DONCASTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Bladder cancer; High grade non muscle invasive; Re resection; Urothelial cancer

Indexed keywords

AGED; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; CYSTECTOMY; DISEASE SPECIFIC SURVIVAL; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NON MUSCLE INVASIVE BLADDER CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; REOPERATION; SURVIVAL RATE; TUMOR INVASION; BLADDER TUMOR; COMPARATIVE STUDY; MIDDLE AGED; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; REOPERATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 85032383070     PISSN: None     EISSN: 24054569     Source Type: Journal    
DOI: 10.1016/j.euf.2017.10.004     Document Type: Article

References (23)

1. Antoni, A., Ferlay, J., Soerjomataram, I., Znaor, A., Jemal, A., Bray, F., Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 71 (2017), 96–108.
2. Svatek, R.S., Hollenbeck, B.K., Holmang, S., et al. The economics of bladder cancer: costs and considerations of caring for this disease. Eur Urol 66 (2014), 253–262.
3. Linder, B.J., Boorjian, S.A., Cheville, J.C., et al. The impact of histological reclassification during pathology re-review?evidence of a Will Rogers effect in bladder cancer?. J Urol 190 (2013), 1692–1696.
4. Sylvester, R.J., van der Meijden, A.P., Oosterlinck, W., et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol, 49, 2006 466–5; discussion 75–7.
5. Kluth, L.A., Black, P.C., Bochner, B.H., et al. Prognostic and prediction tools in bladder cancer: a comprehensive review of the literature. Eur Urol 68 (2015), 238–253.
6. Gontero, P., Sylvester, R., Pisano, F., et al. Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guerin: results of a retrospective multicenter study of 2451 patients. Eur Urol 67 (2015), 74–82.
7. Kulkarni, G.S., Hakenberg, O.W., Gschwend, J.E., et al. An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer. Eur Urol 57 (2010), 60–70.
8. Thomas, F., Noon, A.P., Rubin, N., Goepel, J., Catto, J.W., Comparative outcomes of primary, recurrent and progressive high-risk non-muscle invasive bladder cancer. Eur Urol 63 (2013), 145–154.
9. Hall, M.C., Chang, S.S., Dalbagni, G., et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 178 (2007), 2314–2330.
10. Burger, M., Oosterlinck, W., Konety, B., et al. ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 63 (2013), 36–44.
11. Babjuk, M., Bohle, A., Burger, M., et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71 (2017), 447–461.
12. Brausi, M., Collette, L., Kurth, K., et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 41 (2002), 523–531.
13. Maruniak, N.A., Takezawa, K., Murphy, W.M., Accurate pathological staging of urothelial neoplasms requires better cystoscopic sampling. J Urol 167 (2002), 2404–2407.
14. Gontero, P., Sylvester, R., Pisano, F., et al. The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/grade 3 bladder cancer treated with bacille Calmette-Guerin. BJU Int 118 (2016), 44–52.
15. Herr, H.W., Role of re-resection in non-muscle-invasive bladder cancer. Sci World J 11 (2011), 283–288.
16. Vasdev, N., Dominguez-Escrig, J., Paez, E., Johnson, M.I., Durkan, G.C., Thorpe, A.C., The impact of early re-resection in patients with pT1 high-grade non-muscle invasive bladder cancer. Ecancermedicalscience, 6, 2012, 269.
17. Bishr, M., Lattouf, J.B., Latour, M., Saad, F., Tumour stage on re-staging transurethral resection predicts recurrence and progression-free survival of patients with high-risk non-muscle invasive bladder cancer. Can Urol Assoc J 8 (2014), E306–E310.
18. Gendy, R., Delprado, W., Brenner, P., et al. Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series. BJU Int 117:Suppl 4 (2016), 54–59.
19. Herr, H.W., Donat, S.M., A re-staging transurethral resection predicts early progression of superficial bladder cancer. BJU Int 97 (2006), 1194–1198.
20. Divrik, R.T., Sahin, A.F., Yildirim, U., Altok, M., Zorlu, F., Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. Eur Urol 58 (2010), 185–190.
21. Noon, A.P., Albertsen, P.C., Thomas, F., Rosario, D.J., Catto, J., Competing mortality in patients diagnosed with bladder cancer: evidence of under-treatment in the elderly and females. Br J Cancer 108 (2013), 1534–1540.
22. Panebianco, V., Barchetti, F., de Haas, R., et al. Improving staging in bladder cancer: the increasing role of multiparametric magnetic resonance imaging. Eur Urol Focus 2 (2016), 113–121.
23. de Haas, R.J., Steyvers, M.J., Futterer, J.J., Multiparametric MRI of the bladder: ready for clinical routine?. AJR Am J Roentgenol 202 (2014), 1187–1195.